申请人:THE CLEVELAND CLINIC FOUNDATION
公开号:US20150133514A1
公开(公告)日:2015-05-14
Protein disulfide isomerase inhibitors according to formula I
are described, wherein R
1
is an aryl or cycloalkyl group, R
2
is selected from the group consisting of CN, SO
2
CH
3
, NO
2
, CO
2
R
3
, CONHR
3
, NMe
2
, and CF
3
, R
3
is selected from H or lower alkyl, R
4
is H, halogen, CN, or COOH, and X and Y are C—H or heteroatoms selected from the group consisting of N, O, and S. The protein disulfide isomerase inhibitors can be used for the treatment of cancer in a subject.